| Date Filed | Type | Description |
| 07/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2023 |
4
| Dhanak Dashyant (EVP & Chief Scientific Officer) has filed a Form 4 on INCYTE CORP|
Txns:
| Paid exercise price by delivering 6,044 shares
@ $62.08, valued at
$375.2k
|
|
| 01/30/2023 |
4
| Dhanak Dashyant (EVP & Chief Scientific Officer) has filed a Form 4 on INCYTE CORP|
Txns:
| Sold 2,419 shares
@ $85, valued at
$205.6k
|
|
| 01/24/2023 |
4
| Dhanak Dashyant (EVP & Chief Scientific Officer) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 4,980 shares
@ $0
Granted 16,128 options to buy
@ $83.2, valued at
$1.3M
|
|
| 12/13/2022 |
4
| Dhanak Dashyant (EVP & Chief Scientific Officer) has filed a Form 4 on INCYTE CORP|
Txns:
| Paid exercise price by delivering 533 shares
@ $82.36, valued at
$43.9k
|
|
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/21/2022 |
4
| Dhanak Dashyant (EVP & Chief Scientific Officer) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 15,054 options to buy
@ $74.78, valued at
$1.1M
|
|
| 01/05/2022 |
4
| Dhanak Dashyant (EVP & Chief Scientific Officer) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 8,678 shares
@ $0 |
|
| 12/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2021 |
4
| Dhanak Dashyant (EVP & Chief Scientific Officer) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 379 shares
@ $0
Granted 2,355 shares
@ $0 |
|
| 10/04/2021 |
4
| Dhanak Dashyant (EVP & Chief Scientific Officer) has filed a Form 4 on INCYTE CORP|
Txns:
| Sold 389 shares
@ $68.67, valued at
$26.7k
|
|
| 09/03/2021 |
4
| Dhanak Dashyant (EVP & Chief Scientific Officer) has filed a Form 4 on INCYTE CORP|
Txns:
| Sold 388 shares
@ $76.71, valued at
$29.8k
|
|
| 07/07/2021 |
4
| Dhanak Dashyant (EVP & Chief Scientific Officer) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 7,853 shares
@ $0
Paid exercise price by delivering 1,573 shares
@ $83.58, valued at
$131.5k
Granted 15,054 options to buy
@ $83.58, valued at
$1.3M
|
|
| 07/02/2021 |
4
| Dhanak Dashyant (EVP & Chief Scientific Officer) has filed a Form 4 on INCYTE CORP|
Txns:
| Sold 396 shares
@ $84.09, valued at
$33.3k
|
|
| 06/14/2021 |
4
| Dhanak Dashyant (EVP & Chief Scientific Officer) has filed a Form 4 on INCYTE CORP|
Txns:
| Sold 3,845 shares
@ $87, valued at
$334.5k
Exercised 3,845 options to buy
@ $65.42, valued at
$251.5k
|
|
| 06/03/2021 |
4
| Dhanak Dashyant (EVP & Chief Scientific Officer) has filed a Form 4 on INCYTE CORP|
Txns:
| Sold 395 shares
@ $84.13, valued at
$33.2k
|
|
| 05/05/2021 |
4
| Dhanak Dashyant (EVP & Chief Scientific Officer) has filed a Form 4 on INCYTE CORP|
Txns:
| Sold 396 shares
@ $85.4, valued at
$33.8k
|
|
| 03/03/2021 |
4
| Dhanak Dashyant (EVP & Chief Scientific Officer) has filed a Form 4 on INCYTE CORP|
Txns:
| Sold 395 shares
@ $79.73, valued at
$31.5k
|
|
| 02/03/2021 |
4
| Dhanak Dashyant (EVP & Chief Scientific Officer) has filed a Form 4 on INCYTE CORP|
Txns:
| Sold 961 shares
@ $90, valued at
$86.5k
Sold 395 shares
@ $90, valued at
$35.6k
Exercised 961 options to buy
@ $65.42, valued at
$62.9k
|
|
| 01/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2020 |
4
| Dhanak Dashyant (EVP & Chief Scientific Officer) has filed a Form 4 on INCYTE CORP|
Txns:
| Paid exercise price by delivering 720 shares
@ $82.05, valued at
$59.1k
|
|
| 11/18/2020 |
4
| Dhanak Dashyant (EVP & Chief Scientific Officer) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 1,232 shares
@ $0 |
|
| 11/10/2020 |
4
| Dhanak Dashyant (EVP & Chief Scientific Officer) has filed a Form 4 on INCYTE CORP|
Txns:
| Sold 961 shares
@ $85.17, valued at
$81.8k
Exercised 961 options to buy
@ $65.42, valued at
$62.9k
|
|
| 10/08/2020 |
4
| Dhanak Dashyant (EVP & Chief Scientific Officer) has filed a Form 4 on INCYTE CORP|
Txns:
| Sold 961 shares
@ $91.97, valued at
$88.4k
Exercised 961 options to buy
@ $65.42, valued at
$62.9k
|
|
| 09/10/2020 |
4
| Dhanak Dashyant (EVP & Chief Scientific Officer) has filed a Form 4 on INCYTE CORP|
Txns:
| Sold 961 shares
@ $88.94, valued at
$85.5k
Exercised 961 options to buy
@ $65.42, valued at
$62.9k
|
|
| 08/10/2020 |
4
| Dhanak Dashyant (EVP & Chief Scientific Officer) has filed a Form 4 on INCYTE CORP|
Txns:
| Sold 961 shares
@ $97.8, valued at
$94k
Exercised 961 options to buy
@ $65.42, valued at
$62.9k
|
|
| 07/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2020 |
4
| Dhanak Dashyant (EVP & Chief Scientific Officer) has filed a Form 4 on INCYTE CORP|
Txns:
| Sold 961 shares
@ $91.87, valued at
$88.3k
Exercised 961 options to buy
@ $65.42, valued at
$62.9k
|
|
| 05/08/2020 |
4
| Dhanak Dashyant (EVP & Chief Scientific Officer) has filed a Form 4 on INCYTE CORP|
Txns:
| Sold 961 shares
@ $96.84, valued at
$93.1k
Exercised 961 options to buy
@ $65.42, valued at
$62.9k
|
|
| 04/08/2020 |
4
| Dhanak Dashyant (EVP & Chief Scientific Officer) has filed a Form 4 on INCYTE CORP|
Txns:
| Sold 3,844 shares
@ $85, valued at
$326.7k
Exercised 3,844 options to buy
@ $65.42, valued at
$251.5k
|
|
| 02/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/22/2020 |
4
| Dhanak Dashyant (EVP & Chief Scientific Officer) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 16,428 options to buy
@ $80.5, valued at
$1.3M
|
|
| 12/12/2019 |
4
| Dhanak Dashyant (EVP & Chief Scientific Officer) has filed a Form 4 on INCYTE CORP|
Txns:
| Paid exercise price by delivering 533 shares
@ $95.72, valued at
$51k
|
|
|